We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Bridgewest SODIUM CHLORIDE 0.9% (45mg/5mL) injection BP ampoule (49272)

ARTG ID 49272

ARTG Name

Bridgewest SODIUM CHLORIDE 0.9% (45mg/5mL) injection BP ampoule

Product name

Bridgewest SODIUM CHLORIDE 0.9% (45mg/5mL) injection BP ampoule

ARTG Date

23 June 1994

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

sodium chloride

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

Bridgewest SODIUM CHLORIDE 0.9% (45mg/5mL) injection BP ampoule , Bridgewest Perth Pharma Pty Ltd, CON-1406

10 September 2025

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 10 September 2025 until 1 October 2026.
Pfizer (Australia) SODIUM CHLORIDE 0.9% (45 mg/ 5mL) injection BP ampoule, Pfizer Australia Pty Ltd, CON-1029

1 November 2022

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 1 November 2022 until 1 November 2023.
Pfizer (Australia) SODIUM CHLORIDE 0.9% (45 mg/5 mL) injection BP ampoule, Bridgewest Perth Pharma Pty Ltd, CON-1161

11 September 2023

Section 14 consent

Consent to supply while noncompliant with standards. All relevant batches released from the 11 September 2023 until the 30 September 2025.